A detailed history of State Street Corp transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, State Street Corp holds 173,103 shares of AIM stock, worth $32,889. This represents 0.0% of its overall portfolio holdings.

Number of Shares
173,103
Previous 173,103 -0.0%
Holding current value
$32,889
Previous $64,000 28.13%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

BUY
$0.67 - $1.18 $8,502 - $14,974
12,690 Added 7.91%
173,103 $183,000
Q2 2021

Aug 16, 2021

BUY
$1.93 - $2.39 $309,597 - $383,387
160,413 New
160,413 $345,000

Others Institutions Holding AIM

About AIM ImmunoTech Inc.


  • Ticker AIM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,049,300
  • Market Cap $9.13M
  • Description
  • AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...
More about AIM
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.